Skip to main content
. 2021 Mar 3;10(5):1034. doi: 10.3390/jcm10051034

Figure 1.

Figure 1

Malignant pleural mesothelioma (MPM): Pathogenic mechanisms and therapeutic platforms. (A) Main players involved in MPM onset. (B) Novel therapeutic strategies designed on the basis of disease molecular features.